BioPharmSignal logoBioPharmSignal

Biotech News

Treace Medical Concepts Reports Second Quarter 2026 Financial Results

Treace Medical Concepts (TMCI)Treace Medical ConceptsEarnings

PONTE VEDRA, Fla., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related deformities, today reported financial results for the second

Related news

TMCITreace Medical Concepts2026-07-24 11:05 EST

Treace to Report Second Quarter 2026 Financial Results on August 7, 2026

CVRXCVRx2026-08-06 20:05 EST

CVRx Reports Second Quarter 2026 Financial and Operating Results

APYXApyx Medical2026-08-06 20:05 EST

Apyx Medical Corporation Reports Second Quarter 2026 Financial Results

AORTArtivion2026-08-06 20:05 EST

Artivion Reports Second Quarter 2026 Financial Results

PLSEPulse Biosciences2026-08-06 20:05 EST

Pulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results

HYPRHyperfine2026-08-06 20:05 EST

Hyperfine, Inc. Reports Second Quarter 2026 Financial Results

XTNTXtant Medical2026-08-06 12:00 EST

Xtant Medical to Announce Second Quarter 2026 Financial Results on August 11, 2026

SGHTSight Sciences2026-08-05 20:05 EST

Sight Sciences Reports Second Quarter 2026 Financial Results

NEPHNephros2026-08-05 20:00 EST

Nephros Schedules Second Quarter 2026 Financial Results Conference Call

IRIXIRIDEX2026-08-04 20:05 EST

Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026

View all latest news

Treace Medical Concepts

Bunion and Midfoot Surgery Treace Medical Concepts develops orthopedic systems for the surgical correction of bunions and related midfoot deformities. Its products are designed to address the underlying three-dimensional alignment of the affected anatomy. Lapiplasty Platform The Lapiplasty procedure and associated instrumentation enable...

Recent company news

TMCITreace Medical Concepts2026-08-07 11:05 EST

Treace Medical Concepts Reports Second Quarter 2026 Financial Results

TMCITreace Medical Concepts2026-07-24 11:05 EST

Treace to Report Second Quarter 2026 Financial Results on August 7, 2026

TMCITreace Medical Concepts2026-06-18 11:05 EST

Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System

TMCITreace Medical Concepts2026-06-11 20:05 EST

Treace to Present at the Sidoti Small Cap Conference

TMCITreace Medical Concepts2026-05-08 11:05 EST

Treace Medical Concepts Reports First Quarter 2026 Financial Results

Stock data

Close
4.38 USD
Market cap
225.11M USD
Exchange
NASDAQ
Sector
MedTech
Location
United States